Comparison of controlled and spontaneous respiration on postoperative nausea and vomiting and laryngospasm in children

The comparison of the incidence of post operative nausea and vomiting and laryngospasm in controlled ventilation or spontaneous respiration in children underwent elective inguinal or femoral hernia surgery with general anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012072410385N1

Enrollment

200

Registered

2013-02-04

Start date

2010-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective inguinal or femoral hernia. Bilateral inguinal hernia, without obstruction or gangrene, Unilateral or unspecified inguinal hernia, without obstruction or gangrene, Bilateral femoral hernia, without obstruction or gangrene, Unilateral or unspecified femoral hernia, without obstructio

Interventions

Intervention 1: In spontaneous respiration group, after primary monitoring with ECG, SpO2 and NIBP and after induction of anesthesia with intra-venous fentanyl 1microg/Kg (Rotex Medica Manufactory), t

Treatment - Other

In spontaneous respiration group, after primary monitoring with ECG, SpO2 and NIBP and after induction of anesthesia with intra-venous fentanyl 1microg/Kg (Rotex Medica Manufactory), thiopentone 4mg/K

In control ventilation group, after primary monitoring with ECG, SpO2 and NIBP and after induction of anesthesia with intra-venous fentanyl 1microg/Kg (Rotex Medica Manufactory), thiopentone 4mg/K

Eligibility

Sex/Gender

All

Age

2 Years to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children admitted for elective inguinal or femoral hernia surgery. Exclusion criteria: History of asthma; Fever; Morbid obesity; Cardiac disease; Metabolic disease ; Renal disease; Electrolyte imbalance; SpO2 under %85

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nausea. Timepoint: Every 15 minutes to 6 hours after the end of the intervention. Method of measurement: Questionnaire.;Vomiting. Timepoint: Every 15 minutes to 6 hours after the end of the intervention. Method of measurement: Questionnaire.;Laryngospasm. Timepoint: Every minute to 30 minutes after the end of intervention. Method of measurement: Pulse oxymetry device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahriari Ali

Tehran University of Medical Sciences,

Ashahriari@tums.ac.ir ;alibenmahdi@yahoo.com+98 21 5560 9951

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026